Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Akston, Antengene, Ascletis, Astellas, Astrazeneca, Biohaven, Chi-Med, Clarity, Eubiologics, Gilead Sciences, Glenmark, IGM, Kintor, Novavax, Opthea, Otsuka, Pardes, Pfizer, Pop, Prota, RDIF, Recce, Revive, Sanotize R&D, Scancell, Shionogi, Sumitovant, Sunovion, Telix, Windtree.